Literature DB >> 18397205

Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.

Micah R Chan1, Henry N Young, Yolanda T Becker, Alexander S Yevzlin.   

Abstract

Arteriovenous fistulae (AVF) are widely regarded as the preferred vascular access in hemodialysis patients due to their primary patency and patient survival benefits. While the obesity paradox has been associated with improved cardiovascular morbidity and all-cause mortality in dialysis patients, its long-term vascular access outcomes are less clear. Recent literature has suggested that obese patients may have increased early and late fistula failure. The purpose of this study was to explore the relationships between obesity and vascular access outcomes. We performed a retrospective cohort analysis using the USRDS DMMS Wave 2 data set. All incident dialysis patients as of January 1, 1996, over the age of 18, receiving only hemodialysis as mode of renal replacement therapy were eligible for inclusion. Among other variables, data collected for the DMMS Wave 2 included: type and location of vascular access, AVF maturity, vascular access revision, and failure. Logistic regression analyses were used to examine the relationships between obesity and vascular access outcomes, adjusting for important covariates. In all, 1486 hemodialysis patients were included. Using body mass index (BMI) <30 kg/m(2) as reference, obesity did not emerge as a factor in predicting vascular access revisions or failures. An increased risk of AVF failure to mature was found only in the highest BMI quartile (>or=35 kg/m(2)) (aOR 3.66 [95% CI 1.27-10.55], p = 0.017). Peripheral vascular disease was independently associated with an increased risk of AVF failure (aOR 2.78 [95% CI 1.01-7.63], p = 0.047) and arteriovenous graft (AVG) failure (aOR 1.65 [95% CI 1.03-2.64], p = 0.036). Obesity was not associated with increased AVF or AVG revision rates or failure and only associated with poorer AVF maturity at highest BMI quartile. We conclude that obesity should not preclude placement of AVF as vascular access of choice, except in the very obese where assessment should be individually based.

Entities:  

Mesh:

Year:  2008        PMID: 18397205     DOI: 10.1111/j.1525-139X.2008.00434.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  14 in total

1.  Vascular access creation before hemodialysis initiation and use: a population-based cohort study.

Authors:  Ahmed A Al-Jaishi; Charmaine E Lok; Amit X Garg; Joyce C Zhang; Louise M Moist
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

Review 2.  New Insights into Dialysis Vascular Access: What Is the Optimal Vascular Access Type and Timing of Access Creation in CKD and Dialysis Patients?

Authors:  Karen Woo; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

3.  Association of Race and Ethnicity with Vascular Access Type Selection and Outcomes.

Authors:  Timothy P Copeland; Robert J Hye; Peter F Lawrence; Karen Woo
Journal:  Ann Vasc Surg       Date:  2019-08-30       Impact factor: 1.466

Review 4.  Epidemiology of end-stage kidney disease.

Authors:  Ryan Gupta; Karen Woo; Jeniann A Yi
Journal:  Semin Vasc Surg       Date:  2021-02-04       Impact factor: 1.000

5.  The association of endothelial progenitor cell markers with arteriovenous fistula maturation in hemodialysis patients.

Authors:  Eray Eroglu; Ismail Kocyigit; Berkay Saraymen; Aydin Tuncay; Ertugrul Mavili; Aydin Unal; Huseyin Avcilar; Mustafa Yavuz Koker; Oktay Oymak
Journal:  Int Urol Nephrol       Date:  2016-04-11       Impact factor: 2.370

Review 6.  Management of Obesity in Adults with CKD.

Authors:  Allon N Friedman; Lee M Kaplan; Carel W le Roux; Philip R Schauer
Journal:  J Am Soc Nephrol       Date:  2021-02-18       Impact factor: 10.121

Review 7.  Vascular access today.

Authors:  Konstantinos Pantelias; Eirini Grapsa
Journal:  World J Nephrol       Date:  2012-06-06

8.  The outcome of the primary vascular access and its translation into prevalent access use rates in chronic haemodialysis patients.

Authors:  Claudia Praehauser; Tobias Breidthardt; Cora Nina Moser-Bucher; Thomas Wolff; Katrin Baechler; Thomas Eugster; Michael Dickenmann; Lorenz Gurke; Michael Mayr
Journal:  Clin Kidney J       Date:  2012-06-28

Review 9.  Maturation of arteriovenous fistula: Analysis of key factors.

Authors:  Muhammad A Siddiqui; Suhel Ashraff; Thomas Carline
Journal:  Kidney Res Clin Pract       Date:  2017-12-31

10.  Vascular Function at Baseline in the Hemodialysis Fistula Maturation Study.

Authors:  Laura M Dember; Peter B Imrey; Mai-Ann Duess; Naomi M Hamburg; Brett Larive; Milena Radeva; Jonathan Himmelfarb; Larry W Kraiss; John W Kusek; Prabir Roy-Chaudhury; Christi M Terry; Miguel A Vazquez; Wanpen Vongpatanasin; Gerald J Beck; Joseph A Vita
Journal:  J Am Heart Assoc       Date:  2016-07-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.